• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(小麦胚芽凝集素)中的凝集素可抑制 SARS-CoV-2 及其关注的 Alpha 和 Beta 变体的感染。

Lectin from (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta.

机构信息

Institute of Virology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, 72076 Tübingen, Germany.

出版信息

Int J Mol Sci. 2021 Sep 22;22(19):10205. doi: 10.3390/ijms221910205.

DOI:10.3390/ijms221910205
PMID:34638545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8508056/
Abstract

Even in the face of global vaccination campaigns, there is still an urgent need for effective antivirals against SARS-CoV-2 and its rapidly spreading variants. Several natural compounds show potential as antiviral substances and have the advantages of broad availabilities and large therapeutic windows. Here, we report that lectin from (Wheat Germ Agglutinin) displays antiviral activity against SARS-CoV-2 and its major Variants of Concern (VoC), Alpha and Beta. In Vero B4 cells, WGA potently inhibits SARS-CoV-2 infection with an IC of <10 ng/mL. WGA is effective upon preincubation with the virus or when added during infection. Pull-down assays demonstrate direct binding of WGA to SARS-CoV-2, further strengthening the hypothesis that inhibition of viral entry by neutralizing free virions might be the mode of action behind its antiviral effect. Furthermore, WGA exhibits antiviral activity against human coronavirus OC43, but not against other non-coronaviruses causing respiratory tract infections. Finally, WGA inhibits infection of the lung cell line Calu-3 with wild type and VoC viruses with comparable IC values. Altogether, our data indicate that topical administration of WGA might be effective for prophylaxis or treatment of SARS-CoV-2 infections.

摘要

即使在全球疫苗接种运动的情况下,仍然迫切需要针对 SARS-CoV-2 及其迅速传播的变体的有效抗病毒药物。几种天然化合物显示出作为抗病毒物质的潜力,并且具有广泛可用性和大治疗窗的优点。在这里,我们报告凝集素来自 (麦胚凝集素)对 SARS-CoV-2 及其主要关注变体(Alpha 和 Beta)显示出抗病毒活性。在 Vero B4 细胞中,WGA 强烈抑制 SARS-CoV-2 感染,IC 小于 10ng/mL。WGA 在与病毒预孵育时有效,或者在感染期间添加时有效。下拉测定表明 WGA 与 SARS-CoV-2 的直接结合,进一步加强了抑制游离病毒颗粒的病毒进入可能是其抗病毒作用的作用模式的假设。此外,WGA 对人冠状病毒 OC43 表现出抗病毒活性,但对引起呼吸道感染的其他非冠状病毒无效。最后,WGA 以可比的 IC 值抑制野生型和 VoC 病毒对肺细胞系 Calu-3 的感染。总之,我们的数据表明,WGA 的局部给药可能有效预防或治疗 SARS-CoV-2 感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/e5b00b27e700/ijms-22-10205-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/43a9f2dc46fb/ijms-22-10205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/f88e8c0bdf92/ijms-22-10205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/8fe03a78971c/ijms-22-10205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/5b4a1406b325/ijms-22-10205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/4fb5271d4efe/ijms-22-10205-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/5b60aac52c52/ijms-22-10205-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/e5b00b27e700/ijms-22-10205-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/43a9f2dc46fb/ijms-22-10205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/f88e8c0bdf92/ijms-22-10205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/8fe03a78971c/ijms-22-10205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/5b4a1406b325/ijms-22-10205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/4fb5271d4efe/ijms-22-10205-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/5b60aac52c52/ijms-22-10205-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/8508056/e5b00b27e700/ijms-22-10205-g007.jpg

相似文献

1
Lectin from (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta.(小麦胚芽凝集素)中的凝集素可抑制 SARS-CoV-2 及其关注的 Alpha 和 Beta 变体的感染。
Int J Mol Sci. 2021 Sep 22;22(19):10205. doi: 10.3390/ijms221910205.
2
Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.iota-卡拉胶抑制 SARS-CoV-2 及其关注的 Alpha、Beta、Gamma 和 Delta 变体的复制。
Int J Mol Sci. 2021 Dec 8;22(24):13202. doi: 10.3390/ijms222413202.
3
Antiviral Effect of Budesonide against SARS-CoV-2.布地奈德对 SARS-CoV-2 的抗病毒作用。
Viruses. 2021 Jul 20;13(7):1411. doi: 10.3390/v13071411.
4
Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.3D8 是一种针对 SARS-CoV-2 和多种冠状病毒的核酸水解单链可变片段 (scFv),具有广谱抗病毒活性,在体外具有抗病毒活性。
Viruses. 2021 Apr 9;13(4):650. doi: 10.3390/v13040650.
5
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.具有体外抗病毒活性和免疫调节作用的半胱胺有可能成为治疗 COVID-19 的重新定位药物候选物。
Cells. 2021 Dec 24;11(1):52. doi: 10.3390/cells11010052.
6
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.黄花蒿提取物抑制 SARS-CoV-2 及其两种变体的体外复制。
J Ethnopharmacol. 2021 Jun 28;274:114016. doi: 10.1016/j.jep.2021.114016. Epub 2021 Mar 12.
7
Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.甲型流感病毒缺陷干扰颗粒通过刺激固有免疫对 SARS-CoV-2 复制的体外抗病毒活性。
Cells. 2021 Jul 11;10(7):1756. doi: 10.3390/cells10071756.
8
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.宿主细胞丝氨酸蛋白酶抑制剂 MM3122 治疗和预防 COVID-19 中对 SARS-CoV-2 的疗效。
J Virol. 2024 May 14;98(5):e0190323. doi: 10.1128/jvi.01903-23. Epub 2024 Apr 9.
9
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.乌米酚维在体外对多种冠状病毒的抗病毒活性,包括新型 SARS-CoV-2 病毒。
Viruses. 2021 Aug 23;13(8):1665. doi: 10.3390/v13081665.
10
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.iota-卡拉胶中和 SARS-CoV-2 并抑制其体外复制。
PLoS One. 2021 Feb 17;16(2):e0237480. doi: 10.1371/journal.pone.0237480. eCollection 2021.

引用本文的文献

1
Potential of Postbiotics in the Biodegradation of Antinutrients in Foods.后生元在食品抗营养因子生物降解中的潜力
Probiotics Antimicrob Proteins. 2025 Jul 14. doi: 10.1007/s12602-025-10649-5.
2
Identification of SARS-CoV-2-binding lectins on a commercial lectin array.在商业凝集素芯片上鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2)结合凝集素
Sci Rep. 2025 Jul 1;15(1):21687. doi: 10.1038/s41598-025-01903-5.
3
A Novel Drug Candidate for Sepsis Targeting Heparanase by Inhibiting Cytokine Storm.一种新型药物候选物通过抑制细胞因子风暴靶向肝素酶治疗败血症。

本文引用的文献

1
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease.含ι-角叉菜胶的鼻喷雾剂在专门护理新冠肺炎患者的医院工作人员暴露后预防新冠病毒病中的疗效
Int J Gen Med. 2021 Oct 1;14:6277-6286. doi: 10.2147/IJGM.S328486. eCollection 2021.
2
Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model. Griffithsin 和角叉菜胶联合使用对 SARS-CoV-1 和 2 在假病毒模型中具有抗病毒协同作用。
Mar Drugs. 2021 Jul 26;19(8):418. doi: 10.3390/md19080418.
3
High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019.
Adv Sci (Weinh). 2024 Aug;11(29):e2403337. doi: 10.1002/advs.202403337. Epub 2024 May 29.
4
Glycosylated SARs Cov 2 interaction with plant lectins.糖基化的刺突蛋白与植物凝集素的相互作用。
Glycoconj J. 2024 Jun;41(3):185-199. doi: 10.1007/s10719-024-10154-x. Epub 2024 May 15.
5
A Review of the Leishmanicidal Properties of Lectins.凝集素的杀利什曼原虫特性综述。
Curr Protein Pept Sci. 2024;25(6):443-453. doi: 10.2174/0113892037275751231221053730.
6
Amphiphilic Low-Molecular-Weight Gelators Bearing β---Acetylglucosamine Linked to a Tartaric Acid Scaffold: Synthesis, Self-Assembly and Wheat Germ Agglutinin Binding.带有与酒石酸支架相连的β-乙酰氨基葡萄糖的两亲性低分子量凝胶剂:合成、自组装及与麦胚凝集素的结合
Gels. 2023 Dec 21;10(1):5. doi: 10.3390/gels10010005.
7
Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2.甘露糖结合凝集素作为强效抗 SARS-CoV-2 病毒药物。
Viruses. 2023 Sep 6;15(9):1886. doi: 10.3390/v15091886.
8
Genome-Wide Mining of for Hevein-like Lectins and Their Potential Molecular Mimicry with SARS-CoV-2 Spike Glycoprotein.天然橡胶树中类橡胶素凝集素的全基因组挖掘及其与SARS-CoV-2刺突糖蛋白的潜在分子模拟
Curr Issues Mol Biol. 2023 Jul 14;45(7):5879-5901. doi: 10.3390/cimb45070372.
9
Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.通过凝集素与 Spike 蛋白上的两个聚糖簇结合,实现对 SARS-CoV-2 的不可逆失活。
Biochemistry. 2023 Jul 18;62(14):2115-2127. doi: 10.1021/acs.biochem.3c00109. Epub 2023 Jun 21.
10
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.发现用于开发泛 SARS-CoV-2 治疗药物的铅类天然产物。
Antiviral Res. 2023 Jan;209:105484. doi: 10.1016/j.antiviral.2022.105484. Epub 2022 Dec 8.
大剂量静脉注射维生素 C 可减轻 2019 年严重冠状病毒病的过度炎症反应。
Nutrition. 2021 Nov-Dec;91-92:111405. doi: 10.1016/j.nut.2021.111405. Epub 2021 Jun 26.
4
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.印度马哈拉施特拉邦第二波新冠疫情中出现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白突变,L452R、T478K、E484Q和P681R
Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542.
5
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.德尔塔变异株对抗体中和的敏感性降低。
Nature. 2021 Aug;596(7871):276-280. doi: 10.1038/s41586-021-03777-9. Epub 2021 Jul 8.
6
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021.截至2021年6月,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的传播性增加及其在全球的传播情况。
Euro Surveill. 2021 Jun;26(24). doi: 10.2807/1560-7917.ES.2021.26.24.2100509.
7
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.接种疫苗人群对关注的 SARS-CoV-2 变异株的免疫应答
Nat Commun. 2021 May 25;12(1):3109. doi: 10.1038/s41467-021-23473-6.
8
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2.奎宁抑制 SARS-CoV-2 感染人细胞系。
Viruses. 2021 Apr 9;13(4):647. doi: 10.3390/v13040647.
9
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.B.1.351 谱系 SARS-CoV-2 假病毒对感染性和中和效率的影响。
Viruses. 2021 Apr 7;13(4):633. doi: 10.3390/v13040633.
10
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.SARS-CoV-2 变异株 P.1 对抗体中和的抵抗力增强。
Cell Host Microbe. 2021 May 12;29(5):747-751.e4. doi: 10.1016/j.chom.2021.04.007. Epub 2021 Apr 18.